We unlock value from market dislocations and complex opportunities, investing across a broad range of sectors and stages. This strategy has delivered a 33% IRR on all realised investments over 27 years.
One of the world’s largest green energy projects, ASC is developing a 1,600km subsea cable to bring 1.8 GW of geothermal and hydro-electric power from Iceland to the UK.
Brooklyn ImmunoTherapeutics is a clinical-stage bioresearch company developing IRX-2, a new immunotherapy for cancer.
REG Technologies enables insurance businesses to seamlessly meet their legal and regulatory requirements by monitoring all of a business’s counterparties in real time with very user friendly and efficient software.
Tungsten Corporation is the world’s largest compliant business transaction network. Tungsten enables customers to digitise and automate their invoicing processes, connecting buyers and suppliers for easier, faster and safer global trade.
essDocs is a software company enabling paperless global trade. Over 60,000 businesses worldwide use essDocs to digitise their trade and finance documents and processes.
Having acquired a unique high-altitude Alpine land bank between Verbier and Zermatt, Health Destinations is transforming the beautiful Evolène valley into an exclusive, sustainable world-class Alpine health destination.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
Disruptive Capital Acquisition Company Ltd aims to combine with a financial services company which has a conservative profile and potential for strong and sustainable long-term growth.